Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 12103926 Compounds for treating huntington's disease

Patent 12103926 was granted and assigned to PTC Therapeutics, Inc. on October, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

PTC Therapeutics, Inc.

0

Current Assignee

PTC Therapeutics, Inc.

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Young-Choon Moon0

Suresh Babu0

Nadiya Sydorenko0

Jigar S. Patel0

Jana Narasimhan0

Anuradha Bhattacharyya0

Date of Patent

October 1, 2024

0

Patent Application Number

170407510

Date Filed

March 26, 2019

0

Patent Citations

US Patent 7473784 Benzothiazole and azabenzothiazole compounds useful as kinase inhibitors

0

US Patent 6977255 Therapeutic morpholino-substituted compounds

0

US Patent 7326711 Pyridino[1,2-a]pyrimidin-4-one compounds as anticancer agents

0

US Patent 7399767 Heterocyclic benzo[c]chromene derivatives useful as modulators of the estrogen receptors

0

US Patent 8337941 Fluorescent substrates for monoamine transporters as optical false neurotransmitters

0

US Patent 8563550 Imidazolothiadiazoles for use as protein kinase inhibitors

0

US Patent 8633019 Methods for treating spinal muscular atrophy

0

US Patent 8765747 Fused 2-aminothiazole compounds

0

...

Patent Primary Examiner

Brian E McDowell

0

CPC Code

0

0

0

0

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 12103926 Compounds for treating huntington's disease

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool